Cholesterol drug recalled over glass concerns | Reduction

Cholesterol drug recalled over glass concerns

Excerpt:

(CNN) -- A manufacturer of a popular cholesterol-reducing medication has recalled more than 40 batches of the product after warning that they may contain small particles of glass. Ranbaxy Pharmaceuticals Inc. says it is calling back bottles of its 10-, 20- and 40-milligram tablets of atorvastatin calcium, the generic version of the widely prescribed anti-cholesterol drug Lipitor. A total of 41 lots of 90- and 500-count bottles are subject to the recall, the company said. "The recall is being conducted at the retail level for such select batches that may contain a foreign substance (small glass particles approximately less than 1mm in size)," Ranbaxy's U.S. subsidiary said in a statement on its website.

Concepts:

Pharmaceutical drug Generic drug Food and Drug Administration Pfizer Pharmacology Atorvastatin Recall election

People:

Ranbaxy

Overall Sentiment: 0.058727

Relevance: 0.838756

Sentiment	Quote
0.0657209	Ranbaxy said its action was taken "with the full knowledge" ...
Sentiment Stats:	Number of Quotes: 1 Aggregate Sentiment: 0.0657209 Mean: 0.0657209 Standard Deviation: 1.4142135623731

Key:

• Aggregate Sentiment is meant to be an indicator of an individual's overall sentiment.
• The Mean is meant to be an indicator of an individual's average comment sentiment.
• The Standard Deviation, when there are enough quotes, will indicate an individual's consistency of sentiment (i.e. a Standard Deviation of 0 would mean they were very consistent in their sentiment and 1 would mean they were very inconsistent).

Note that quote stats are likely to be meaningless beyond the aggregate score due to the tiny sample size. However, they are always provided just in case you find something useful there.

Additional Info:

Country: U.S.

Overall Sentiment: 0

Relevance: 0.556647

Disambiguation: Location | Region | AdministrativeDivision | GovernmentalJurisdiction | FilmEditorReferences:

• United States
• United States: dbpedia
• United States: freebase
• United States: ciaFactbook
• United States: opencyc
• United States: yago

StateOrCounty: New Jersey

Overall Sentiment: 0.160309

Relevance: 0.423753

Disambiguation: Location | PoliticalDistrict | AdministrativeDivision | GovernmentalJurisdiction | USStateReferences:

• New Jersey
• New Jersey: dbpedia
• New Jersey: freebase
• New Jersey: umbel
• New Jersey: opencyc
• New Jersey: yago

Organization: U.S. Food and Drug Administration

Overall Sentiment: -0.115372

Relevance: 0.919719

Disambiguation: References:

• U.S. Food and Drug Administration: dbpedia
• U.S. Food and Drug Administration: opencyc

Organization: Justice Department

Overall Sentiment: -0.249471

Relevance: 0.469195

Disambiguation: GovernmentAgency | GovernmentalBody | GovernmentalJurisdictionReferences:

• United States Department of Justice
• United States Department of Justice: dbpedia
• United States Department of Justice: freebase
• United States Department of Justice: yago

Company: Ranbaxy Pharmaceuticals Inc.

Overall Sentiment: 0

Relevance: 0.725135

Company: CNN

Overall Sentiment: 0.147217

Relevance: 0.523161

Disambiguation: BroadcastReferences:

• CNN International
• CNN International: dbpedia
• CNN International: freebase
• CNN International: umbel
• CNN International: yago

Drug: atorvastatin

Overall Sentiment: 0.104342

Relevance: 0.523688

Webpage Meta Tags Details

Source Webpage: http://rss.cnn.com/~r/rss/cnn_us/~3/TM3EiDswodk/index.html

URL Provided Desc:

A manufacturer of a popular cholesterol-reducing medication has recalled more than 40 batches of the product after warning that they may contain small particles of glass.

URL Provided Keywords:

Provided Title:

Cholesterol drug recalled over glass concerns

Data Sources

Full Content: http://rss.cnn.com/~r/rss/cnn_us/~3/TM3EiDswodk/index.html

http://www.alchemyapi.com/